Literature DB >> 15858823

Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma.

Julie Osborne1, Annette Lake, Freda E Alexander, G Malcolm Taylor, Ruth F Jarrett.   

Abstract

Somatic inactivation of NFKBIA, the gene encoding IkappaBalpha, is a frequent occurrence in the malignant Hodgkin and Reed-Sternberg (HRS) cells of Hodgkin lymphoma (HL). Impairment of IkappaBalpha function results in deregulated NF-kappaB activity, a characteristic of HRS cells. The molecular basis for familial HL, which accounts for approximately 4% of all HL cases, is unclear. To date, familial HL cases have not been evaluated for germline NFKBIA mutations. We screened the entire NFKBIA gene in 8 individuals with familial HL but found no mutations in the coding region or promoter sequences. We identified the first germline NFKBIA missense mutation in a patient with presumed sporadic HL. The frequency of 4 polymorphisms within the NFKBIA gene and promoter region was investigated in a series of HL and control samples; no significant differences emerged but a novel polymorphism was identified in the promoter region. Overall, our results suggest that germline mutations of NFKBIA are not a significant cause of familial aggregation of HL but may contribute to inherited susceptibility to HL. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858823     DOI: 10.1002/ijc.21036

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  NFKBIA deletion in glioblastomas.

Authors:  Markus Bredel; Denise M Scholtens; Ajay K Yadav; Angel A Alvarez; Jaclyn J Renfrow; James P Chandler; Irene L Y Yu; Maria S Carro; Fangping Dai; Michael J Tagge; Roberto Ferrarese; Claudia Bredel; Heidi S Phillips; Paul J Lukac; Pierre A Robe; Astrid Weyerbrock; Hannes Vogel; Steven Dubner; Bret Mobley; Xiaolin He; Adrienne C Scheck; Branimir I Sikic; Kenneth D Aldape; Arnab Chakravarti; Griffith R Harsh
Journal:  N Engl J Med       Date:  2010-12-22       Impact factor: 91.245

2.  Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.

Authors:  Ellen T Chang; Brenda M Birmann; Julie L Kasperzyk; David V Conti; Peter Kraft; Richard F Ambinder; Tongzhang Zheng; Nancy E Mueller
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-17       Impact factor: 4.254

3.  Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.

Authors:  David H Dreyfus; Yang Liu; Lucy Y Ghoda; Joseph T Chang
Journal:  Virol J       Date:  2011-09-05       Impact factor: 4.099

4.  Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors.

Authors:  Caroline N Mills; Somaira Nowsheen; James A Bonner; Eddy S Yang
Journal:  Front Mol Neurosci       Date:  2011-11-25       Impact factor: 5.639

5.  Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis.

Authors:  Meng Zhang; Junjie Huang; Xiuxiu Tan; Jian Bai; Hao Wang; Yukun Ge; Hu Xiong; Jizhou Shi; Wei Lu; Zhaojie Lv; Chaozhao Liang
Journal:  Med Sci Monit       Date:  2015-10-21

6.  KLF6 depletion promotes NF-κB signaling in glioblastoma.

Authors:  A P Masilamani; R Ferrarese; E Kling; N K Thudi; H Kim; D M Scholtens; F Dai; M Hadler; T Unterkircher; L Platania; A Weyerbrock; M Prinz; G Y Gillespie; G R Harsh; M Bredel; M S Carro
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

7.  Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.

Authors:  Kristin L White; Robert A Vierkant; Catherine M Phelan; Brooke L Fridley; Stephanie Anderson; Keith L Knutson; Joellen M Schildkraut; Julie M Cunningham; Linda E Kelemen; V Shane Pankratz; David N Rider; Mark Liebow; Lynn C Hartmann; Thomas A Sellers; Ellen L Goode
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

8.  Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.

Authors:  Zhaohui Zhao; Xingming Zhong; Tinfeng Wu; Tianquan Yang; Guilin Chen; Xueshun Xie; Yongxin Wei; Ming Ye; Youxin Zhou; Ziwei Du
Journal:  Int J Mol Med       Date:  2014-09-12       Impact factor: 4.101

Review 9.  Genetic Association Between NFKBIA -881A>G Polymorphism and Cancer Susceptibility.

Authors:  Peiliang Geng; Juanjuan Ou; Jianjun Li; Yunmei Liao; Ning Wang; Rina Sa; Lisha Xiang; Houjie Liang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

10.  The relative timing of mutations in a breast cancer genome.

Authors:  Scott Newman; Karen D Howarth; Chris D Greenman; Graham R Bignell; Simon Tavaré; Paul A W Edwards
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.